8 min. read

Digital vaccines, really? FDA De Novo for IBS.

PLUS: A Wittgenstein's Ladder reference

Issue 080

 E&O Fridays.

Welcome back. Two weeks ago in E&O Fridays, I speculated about the Amwell-Omada price tag (I think we'll hear about this deal around

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Recent Articles